The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

FTSE 100 movers: AstraZeneca leads after revenue beats expectations

Thu, 24th Apr 2014 14:33

AstraZeneca rose on the back of better-than-expected revenue growth of three per cent in the first quarter, driven by the pharmaceutical company's diabetes franchise. Shares were up despite earnings falling more than expected. AstraZeneca's share price surged earlier this week on speculation it could be susceptible to a takeover bid from Pfizer.The news helped peers Smith & Nephew and Shire higher, which were also rising on readacross from the US, where medical device maker Zimmer Holdings is set to buy Biomet in a deal worth $13.35bn. Diversified miner Anglo American was making decent gains after impressing with production increases ahead of expectations across the board. Espirito Santo reiterated its 'neutral' rating on the stock. easyJet climbed on the back of a target price increase from Morgan Stanley, which also gave the stock an 'overweight' rating. It said: "We forecast a 3% yield in 2015 in a sector where we expect few carriers to deliver a payout." The bank also issued an upbeat statement about IAG, saying the pre-Easter sell-off was "aggressive" with the group dropping 15% in 10 days, "despite no company specific newsflow or signs of changes to IAG earnings drivers". It continued: "After a first quarter of underperformance, and indeed negative year to date performance versus 20%-45% at peers, we see grounds for investor sentiment to turn positive from here into May 9th first quarter earnings. Free cashflow yield on our 2015 estimate is a healthy 16% post capital expenditure and in a year when we expect IAG to initiate a dividend payout." Meanwhile, building materials supplier Travis Perkins fell sharply despite a strong first-quarter report, which is most likely due to profit taking. Consumer goods giant Unilever signalled an upturn in Europe in its first quarter, but said growth was slowing in emerging markets as it reported a 6.3% fall in turnover to €11.4bn due to currency headwinds, causing shares to drop.Hammerson fell after HSBC downgraded the real estate investment trust from 'overweight' to 'neutral'.Associated British Foods retreated from yesterday's strong gains which came after the company announced its intention to expand its fast-growing Primark brand into the US towards the end of next year. FTSE 100 - RisersAstraZeneca (AZN) 4,206.50p +4.06%Shire Plc (SHP) 3,295.00p +3.32%Smith & Nephew (SN.) 904.00p +2.79%easyJet (EZJ) 1,722.00p +2.14%International Consolidated Airlines Group SA (CDI) (IAG) 415.90p +2.11%Petrofac Ltd. (PFC) 1,437.00p +2.06%Mondi (MNDI) 1,016.00p +1.96%Anglo American (AAL) 1,575.50p +1.84%InterContinental Hotels Group (IHG) 1,984.00p +1.80%Hargreaves Lansdown (HL.) 1,216.00p +1.59%FTSE 100 - FallersTravis Perkins (TPK) 1,792.00p -2.18%Unilever (ULVR) 2,577.00p -2.16%Hammerson (HMSO) 573.50p -1.21%Fresnillo (FRES) 843.00p -1.17%Associated British Foods (ABF) 2,928.00p -1.15%William Hill (WMH) 331.30p -1.13%Sports Direct International (SPD) 790.00p -0.88%Ashtead Group (AHT) 870.00p -0.80%Pearson (PSON) 1,049.00p -0.66%Randgold Resources Ltd. (RRS) 4,672.00p -0.60%NR

Related Shares

More News
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announ...

3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...

2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.